PROCEPT BioRobotics (NASDAQ:PRCT) & Kewaunee Scientific (NASDAQ:KEQU) Financial Survey

Kewaunee Scientific (NASDAQ:KEQU) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Profitability

This table compares Kewaunee Scientific and PROCEPT BioRobotics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	2.97%	11.61%	4.82%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

Analyst Ratings

This is a summary of current recommendations and price targets for Kewaunee Scientific and PROCEPT BioRobotics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0	1	0	0	2.00
PROCEPT BioRobotics	2	9	2	3	2.38

PROCEPT BioRobotics has a consensus target price of $25.50, indicating a potential upside of 27.76%. Given PROCEPT BioRobotics’ stronger consensus rating and higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Kewaunee Scientific.

Insider and Institutional Ownership

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Kewaunee Scientific has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Valuation & Earnings

This table compares Kewaunee Scientific and PROCEPT BioRobotics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$277.21 million	0.34	$9.62 million	$2.76	11.88
PROCEPT BioRobotics	$337.34 million	3.39	-$95.57 million	($1.94)	-10.29

Kewaunee Scientific has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Summary

PROCEPT BioRobotics beats Kewaunee Scientific on 8 of the 15 factors compared between the two stocks.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

About PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.